These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9754389)

  • 1. [Mitochondrial DNA and Parkinson disease. Methodologic review].
    Pautot V; Macaigne C; Chariot P
    Arch Anat Cytol Pathol; 1998; 46(4):261-8. PubMed ID: 9754389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling neurodegenerative diseases in vivo review.
    von Bohlen Und Halbach O
    Neurodegener Dis; 2005; 2(6):313-20. PubMed ID: 16909014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Burns RS; LeWitt PA; Ebert MH; Pakkenberg H; Kopin IJ
    N Engl J Med; 1985 May; 312(22):1418-21. PubMed ID: 2581135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA analysis in Parkinson's disease.
    Schapira AH; Holt IJ; Sweeney M; Harding AE; Jenner P; Marsden CD
    Mov Disord; 1990; 5(4):294-7. PubMed ID: 1979656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contribution of MPTP to studies on the pathogenesis of Parkinson's disease].
    Mizuno Y
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1494-6. PubMed ID: 2698296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence analysis of the entire mitochondrial genome in Parkinson's disease.
    Vives-Bauza C; Andreu AL; Manfredi G; Beal MF; Janetzky B; Gruenewald TH; Lin MT
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1593-601. PubMed ID: 11820805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and animal studies of Parkinson's disease.
    Oertel WH; Kupsch A
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences].
    Luquin MR; Obeso JA; Herrero MT; Laguna J; Martínez-Lage JM
    Neurologia; 1991 Oct; 6(8):287-94. PubMed ID: 1790005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.
    Gu M; Cooper JM; Taanman JW; Schapira AH
    Ann Neurol; 1998 Aug; 44(2):177-86. PubMed ID: 9708539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mitochondrial DNA mutations in Parkinson's disease.
    Richter G; Sonnenschein A; Grünewald T; Reichmann H; Janetzky B
    J Neural Transm (Vienna); 2002 May; 109(5-6):721-9. PubMed ID: 12111463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MPTP model of Parkinson's disease.
    Smeyne RJ; Jackson-Lewis V
    Brain Res Mol Brain Res; 2005 Mar; 134(1):57-66. PubMed ID: 15790530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].
    Lange KW
    Fortschr Neurol Psychiatr; 1989 Apr; 57(4):142-8. PubMed ID: 2656447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MPTP: a pharmacological tool to study parkinsonism.
    Kulkarni SK; Mehta AK; Aley KO; Shukla VK
    Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):485-9. PubMed ID: 3489146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings.
    Braungart E; Gerlach M; Riederer P; Baumeister R; Hoener MC
    Neurodegener Dis; 2004; 1(4-5):175-83. PubMed ID: 16908987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates.
    Jakowec MW; Petzinger GM
    Comp Med; 2004 Oct; 54(5):497-513. PubMed ID: 15575363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mitochondria in Parkinson disease.
    Kösel S; Hofhaus G; Maassen A; Vieregge P; Graeber MB
    Biol Chem; 1999; 380(7-8):865-70. PubMed ID: 10494835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron-dependent enzymes in Parkinson's disease.
    Reichmann H; Janetzky B; Riederer P
    J Neural Transm Suppl; 1995; 46():157-64. PubMed ID: 8821051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.